Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Added a few pre-market. And why not? With these weight-loss drugs, gonna be a lot of flabby faces staring people in the mirror, asking for a lift. 60% said they would think about it. Money in the bank.
Anyone have a good read on 1Q24 revenue? Quarter ends this week.
LOL! What a clown you are! What circus did you pop up from? Five posts, and all basically the same. Going out of business vibe? Really?
From last quarter earnings:
"Q4 and full year 2023 product revenue (DAXXIFY® and RHA® Collection) of $58.5 million and $212.7 million, representing approximately 28% and 80% YoY growth, respectively.
– Q4 DAXXIFY volume up 22% over Q3 2023, with over two-thirds of Q4 revenue attributable to reordering accounts.
– 2024 product revenue guidance of at least $280 million, supporting blockbuster potential in U.S. aesthetics."
And these guys here--fools! Paying $6.25/share for a company going out of business! Hey, clownboy (or should I say, girl?), you think the bankruptcy speil helped them to sell shares? You never know. Some fools are always looking to buy into bankrupt biotechs.
Maybe this has already been posted, but here goes. From Jonah Lupton on X.
"In a recent survey (done by Needham) of users of GLP-1 drugs, 62% of the respondents said they are now more likely to get aesthetic/cosmetic procedures (to help with skin tightening) and/or begin using injectables like Botox and $EOLS Jeuveau as well as fillers to help with overall skin appearance.
This is bullish for $INMD and $EOLS (I own both). Also good for $ABBV which owns Allergan which makes Botox."
Of course, he didn't mention rvnc, but several others in the thread did.
I mean, the data from the survey makes sense. Overweight people who lose weight feel good about themselves, and when they look in the mirror, they might think, "Hey, while I'm at it, why don't I do something about my face?"
Could be onto something here.
I haven't posted in a while, but, it seems, earnings wasn't as bad as many expected here--no? In fact, I'd argue that it was very good. 2024 guidance as well. We are probably looking at $300M (Foley said "at last $280M." We will also have CD on board, bring in revenue.
In any case, I tripled down today at $5.30 after selling last night at $6.30. Largest position in my biotech portfolio. This is an easy buy.
Added a few today, after getting back in. Good r/r if one has the time.
Agreed. It's a winner LT. Just so much bad sentiment around the stock. Had the numbers been better, of course I wouldn't have risked it. But they weren't outstanding. Added a few more just now.
I sold today at $8.20 and bought back at $6.84, and why not? I took one look at the sales numbers and said, and compared them with the projections on this board, and said to myself, "This doesn't look great."
Not bad numbers. A good buy at these levels. Will add if it drops more.
IMO, if numbers are good, they should release them this week, during JPM.
Do you expect them to release numbers and guidance this week, during JPM?
When will we see the numbers? Next week?
What in the hell is wrong with this thing today, a few days prior to providing preliminary earnings and guidance? Hangover from lawsuit news yesterday?
Hope so. And hope they knock it out of the park. Thanks.
Are we sure there will announce preliminary numbers and guidance next week?
Any chance mgmnt will give 2024 guidance in the coming weeks?
Doubling 2023 sales? I'll take that.
Probably is FUD. He probably doesn't even know that it's TRUE:
some dude on Stocktwits, probably spreading FUD: “We are ahead of Q4 plan/sales quotas” - sales rep
Still say there's something more than nothing we don't know about.
The lawsuit?
Agreed. Just find the crushing, grueling downward trend troubling, when most bios are rebounding. Most.
Curious price action. What's holding it back? Of course, er sucked, but it looks like 4Q will be better. Lots of good press as well.
Is is the alleged lawsuit? Is it serious?
Thanks for the reply. Hard to take this price action. Hardly any upward movement at all.
What was the answer, if you don't mind my asking?
Does the lawsuit have legs? Apparently not.
while everyone else was crying, hysterically, the sky was falling, I calmly added. Nothing really has changed; in fact, over the last month or so, a lot of positive changes have been made, as well as the positive press they have been getting, namely, in Time Magazine and Glamour. Whatever you may say, the value of this company is worth more than a market cap of $500M. When it was at $4B, yes, it was certainly over-valued, and shorts did well to attack. Hopefully, it will find its own, real, value in due time.
Did you get the sense that they were heading in the right direction? It sure sounded like it in the 3Q cc.
Dear Aestheticexec: cut your short position before it's too late. Or sell eols and by rvnc. You don't know what you're talking about.
The doc contradicted himself in the last three sentences. Words are facile.
thanks.
I am sure you guys have covered this before on the board, but I have a few questions about TEOXANE:
1) what is their end-game with Revance?
2) would they be interested in acquiring Revance?
3) do they have the money?
Thanks
Sounds to me like eols ceo knows what he's doing. Will be interesting (painful?) to watch the race over the next few quarters.
Just listened to the 3Q cc. I have no particular insight, but unless they are lying, 4Q, due to pricing strategy and seasonality, will be much better than 3Q. Brilliant observation? Stupid one, I would say, but that is precisely my point: if you look at the share price, it seems everyone has assumed they're going bankrupt.
good, informative, fair post.
Given your background and experience, where do you see rvnc and daxxify in one year? Do you really think they've burned their commercial bridge, so to speak?
Good to know. I'm going to spend some time this weekend listening to cc, as well as reading up. Thanks.
Hope you're right re 4Q. In any case, people are WAY too pessimistic.
Is there a viable market for CD? It is realistic to expect peak sales of $350M? How long do you think it will take?
I I have been adding over the last week. Pretty drastic drop, from $37 to $6. People expecting the company to go bankrupt. We'll see what the next few quarters bring.
Oh, I don't think it is that simple. For one thing, based on revenue, they haven't had many customers in the first two quarters; so you're is faulty. Investors are jumping to conclusions here. I added today.
So much confusion out there. Once on top of M&A lists, now people are talking about bankruptcy. Sure, we all know about the errors and miscalculations in on the sales and marketing side, but has the product changed? has the market? Does anyone seriously think the company has been written off?
the post from the other board (stocktwits) is from pablosplace13. A rabid eols cheerleader. He might or might not know what's he talking about, but he has badtalked daxxify for years now; so take his comments with a grain of salt.